ArticleAntimicrobial agents and chemotherapy2020

Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS).

Tristan T Timbrook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.